SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072173
Filing Date
2022-11-14
Accepted
2022-11-14 16:03:44
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_aditxt.htm   iXBRL 10-Q 955965
2 CERTIFICATION f10q0922ex31-1_aditxtinc.htm EX-31.1 12168
3 CERTIFICATION f10q0922ex31-2_aditxtinc.htm EX-31.2 11796
4 CERTIFICATION f10q0922ex32-1_aditxtinc.htm EX-32.1 5171
  Complete submission text file 0001213900-22-072173.txt   4908914

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20220930.xsd EX-101.SCH 68786
6 XBRL CALCULATION FILE adtx-20220930_cal.xml EX-101.CAL 31421
7 XBRL DEFINITION FILE adtx-20220930_def.xml EX-101.DEF 238950
8 XBRL LABEL FILE adtx-20220930_lab.xml EX-101.LAB 572283
9 XBRL PRESENTATION FILE adtx-20220930_pre.xml EX-101.PRE 255596
52 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_aditxt_htm.xml XML 481996
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39336 | Film No.: 221384993
SIC: 2834 Pharmaceutical Preparations